A Study of Various Treatments in Serous or p53 Abnormal Endometrial Cancer

NCT04159155 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped Low accrual

Conditions

Endometrial Carcinoma
P53 Mutation
Serous Carcinoma

Interventions

RADIATION: External Beam Radiation
DRUG: Niraparib
RADIATION: Vaginal high-dose rate brachytherapy
OTHER: Observation - no drugs

Sponsor

University Health Network, Toronto